Andrew F. Berdel

University Hospital Münster — Germany

Medicine · Health Sciences

6h-index84citations22works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peptidase Inhibition and Analysis(9), Acute Myeloid Leukemia Research(5), Cardiac tumors and thrombi(4), Multiple Myeloma Research and Treatments(3), Neuroendocrine Tumor Research Advances(3)

Publications22 total

Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy
Scientific Reports·2026Open Access
Impact of European LeukemiaNet–guided postremission therapy on outcomes of patients with AML from 2010 to 2022
ETH Zürich Research Collection·2025Open Access
Relapse after allogeneic hematopoietic stem cell transplantation in patients with active acute myeloid leukemia
Leukemia Research·2025Open Access
Impact of European LeukemiaNet–guided postremission therapy on outcomes of patients with AML from 2010 to 2022
Blood Neoplasia·2025Open Access
Real-world experience with IDH inhibitors in Acute Myeloid Leukemia: A german multicenter analysis with a focus on differentiation syndrome
Blood·2025Open Access
2711P Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: Translational data, clinical safety and efficacy
Annals of Oncology·2025
Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment
Leukemia·2025Open Access
Abstract 824: Comparative pharmacokinetics (PK) of targeted tissue factor tTF-NGR when intravenously applied alone or in combination with preceding trabectedin
Cancer Research·2025
Common hereditary variants of the <i>APOE</i> gene and posttransplant outcome in acute myeloid leukemia
Blood·2025· 2 cited
Photodynamic ROS inducers delivered <i>via</i> electrostatic antibody targeted (ELART) nanocarriers incorporate into tumour cells and inhibit colony growth
Chemical Communications·2025Open Access
“As Treated” Validation of the European LeukemiaNet (ELN) Classification for Adult Acute Myeloid Leukemia (AML) Patients (pts) Treated in a Large AML-Referral Center from 2010-2022
Blood·2024Open Access
Abstract 4606: Combinatorial effects of a sequence of trabectedin (T) and CD13-targeted tissue factor tTF-NGR on human vascular endothelial cells (HUVEC) and in soft tissue sarcoma (STS) models
Cancer Research·2024
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
Annals of Hematology·2022· 1 citedOpen Access
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
Blood Advances·2022· 10 citedOpen Access
Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease
Cancers·2021· 7 citedOpen Access
A Phase I Trial of the Antibody-Cytokine Fusion Protein F16IL2 in Combination with Anti-CD33 Immunotherapy for Posttransplant AML Relapse
Blood·2021· 5 cited
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction
Cancers·2021· 8 citedOpen Access
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas
European Journal of Cancer·2021· 15 cited
Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation
British Journal of Haematology·2021· 7 cited
Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?
Cancers·2020· 6 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Christoph Schliemann(20), Georg Lenz(18), Wolfgang E. Berdel(17), Torsten Keßler(11), Linus Angenendt(10), Christian Schwöppe(9), Matthias Stelljes(8), Mirjam Gerwing(7), Wolfgang Hartmann(7), Klaus Wethmar(7), Julian Ronnacker(6), Saliha Harrach(5), Rolf M. Mesters(5), Jan‐Henrik Mikesch(5), Caroline Brand(5), Heike Hintelmann(5), Christian Reicherts(5), Eva Wardelmann(4), Walter Heindel(4), Teresa Hemmerle(4)